1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsExploratory Grant Program in Diabetes Endocrinology and Metabolism (R21) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Pilot and Feasibility Clinical Research Grants in Diabetes, and Endocrine and Metabolic Diseases (R21) - NCCOR Pilot and Feasibility Clinical Research Grants in Diabetes, and Endocrine and Metabolic Diseases (R21) This Funding Opportunity Announcement (FOA), issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health, encourages pilot and feasibility clinical and behavioral studies related to the prevention or treatment of diabetes and endocrine and genetic metabolic diseases.
The Pilot and Feasibility Clinical Research Grants Program is for exploratory, short-term clinical studies, so that new ideas may be investigated without stringent requirements for preliminary data. The short-term studies should focus on research questions that are likely to have high clinical impact. Studies can include testing a new prevention strategy, a new intervention or a unique combination of therapies.
A high priority is the use of such studies to help stimulate the translation of promising research developments from the laboratory into clinical practice in the treatment or prevention of diabetes, endocrine diseases and genetic metabolic diseases, including cystic fibrosis. Cycle Due Dates (new submission): Feb. 16, June 16, Oct.
16 Direct costs are limited to $275,000 over a two-year period, with no more than $200,000 in direct costs allowed in any single year. Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support.
Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. http://grants. nih.
gov/grants/guide/pa-files/PA-12-157. html Check us out on Facebook, LinkedIn,
According to the current listing, eligibility includes: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to…. Confirm the full requirements in the official notice before applying.
The current listing shows $275,000 total direct costs over two years, with no more than $200,000 in any single year. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Exploratory Grant Program in Diabetes Endocrinology and Metabolism (R21) are due October 16, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Exploratory Grant Program in Diabetes Endocrinology and Metabolism (R21) is funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.